标题
Genetic and genomic predictors of anti-TNF response
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 12, Issue 11, Pages 1571-1585
出版商
Future Medicine Ltd
发表日期
2011-11-02
DOI
10.2217/pgs.11.114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis
- (2011) Gary Toedter et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
- (2011) T. Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
- (2011) L. Peyrin-Biroulet et al. GUT
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
- (2010) Matthias Jürgens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment
- (2010) R. J. L. Tan et al. ANNALS OF THE RHEUMATIC DISEASES
- Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients
- (2010) L. R. Coulthard et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways
- (2010) C. Potter et al. ANNALS OF THE RHEUMATIC DISEASES
- Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci
- (2010) Darren Plant et al. ARTHRITIS AND RHEUMATISM
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
- (2010) Eli A Stahl et al. NATURE GENETICS
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
- (2010) Andre Franke et al. NATURE GENETICS
- Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study
- (2010) Marian Suarez-Gestal et al. ARTHRITIS RESEARCH & THERAPY
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients With Rheumatoid Arthritis
- (2009) B Stuhlmüller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions
- (2009) Robert M Plenge et al. CURRENT OPINION IN RHEUMATOLOGY
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- Genome wide association (GWA) predictors of anti-TNFα therapeutic responsiveness in pediatric inflammatory bowel disease
- (2009) Marla C. Dubinsky et al. INFLAMMATORY BOWEL DISEASES
- Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk
- (2009) Soumya Raychaudhuri et al. NATURE GENETICS
- Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients
- (2009) John D. Bowes et al. Pharmacogenetics and Genomics
- TNF-α −308 G/A polymorphism and responsiveness to TNF-α blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis
- (2009) D D O'Rielly et al. PHARMACOGENOMICS JOURNAL
- An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis
- (2009) Antonio Julià et al. PLoS One
- Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
- (2009) Wolfgang Hueber et al. ARTHRITIS RESEARCH & THERAPY
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
- (2008) C Potter et al. ANNALS OF THE RHEUMATIC DISEASES
- Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
- (2008) T R D J Radstake et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
- (2008) Hubert Marotte et al. ARTHRITIS AND RHEUMATISM
- Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis
- (2008) James R. Maxwell et al. HUMAN MOLECULAR GENETICS
- Unknown
- (2008) Chunyu Liu et al. MOLECULAR MEDICINE
- An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome
- (2008) Benjamin L Ebert et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now